Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • John Snow Labs Closes Record Year with 5x Customer Growth in 2021

    Jan 6, 2022, 16:56 PM by
    John Snow Labs makes its Annotation Lab and NLP Server tools free to all users after a year of record growth.
    Full story
  • MDI Biological Laboratory Awarded Grant to Advance Cloud Computing in Maine

    Jan 6, 2022, 16:56 PM by
    The MDI Biological Laboratory in Bar Harbor, Maine, has been awarded a grant to promote the shift to cloud computing among undergraduates and researchers at the 14 Maine educational and research institutions that comprise the federally funded Maine INBRE network, a program to strengthen biomedical research and research training in Maine.
    Full story
  • Positive Technologies Offers Solutions to Cope with Critical Vulnerability in Popular Log4j Library

    Jan 6, 2022, 16:56 PM by
    Positive Technologies announced that its solutions, MaxPatrol VM, PT Network Attack Discovery and PT Application Firewall can be used to help mitigate the risks associated with the widespread Log4j vulnerability.
    Full story
  • Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies

    Jan 6, 2022, 16:56 PM by
    Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies.
    Full story
  • Curebase Technology Key to metaMe Health’s FDA Clearance of Regulora

    Jan 6, 2022, 16:56 PM by
    Clinical research for Regulora was successfully completed using Curebase’s decentralized clinical trial (DCT) technology and services.
    Full story
  • Ashfield Engage, Alliance Medical and NHS partner to identify early-stage lung cancer

    Jan 6, 2022, 16:56 PM by
    Full story
  • Alfa Chemistry Semiconductor: A Diverse Portfolio to Support Semiconductor Research

    Jan 6, 2022, 16:56 PM by
    Full story
  • ZeOmega Adds Industry Leader to Management Team to Help Drive Payer and Provider Evolution into New Era of Value-based Care and Data-driven Quality and Experience

    Jan 6, 2022, 16:56 PM by
    Full story
  • X-Therma Closes Oversubscribed $13M Series A Financing Led by LOREA AG

    Jan 6, 2022, 16:56 PM by
    X-Therma closes an oversubscribed $13M Series A financing round led by LOREA AG. Funding will advance its breakthrough product platform rewriting biopreservation and cold chain.
    Full story
  • Curebase Joins WCG Avoca Quality Consortium

    Jan 6, 2022, 16:56 PM by
    Curebase Joins WCG Avoca Quality Consortium
    Full story
  • Ribo-Seq Service Now Available on CD Genomics’s RNA Solutions Platforms

    Jan 6, 2022, 16:56 PM by
    Full story
  • Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

    Jan 6, 2022, 16:56 PM by
    Bioinformatics-analysis Platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics has recently announced Epigenetics Data Analysis to move your disease research forward.
    Full story
  • CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions

    Jan 6, 2022, 16:56 PM by
    Full story
  • CD Formulation Optimizes Elemental Impurities Analysis Service

    Jan 6, 2022, 16:56 PM by
    Full story
  • New scientific advisory Board at Qlucore

    Jan 6, 2022, 16:56 PM by
    Qlucore, provider of intuitive bioinformatics software for research and precision and companion diagnostics, announces the creation of a Scientific Advisory Board (SAB), consisting of five members, chaired by Carl-Johan Ivarsson, CEO of Qlucore.
    Full story
  • Emmes Acquires Institut Dr. Schauerte

    Jan 6, 2022, 16:56 PM by
    Full story
  • WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site

    Jan 6, 2022, 16:56 PM by
    Full story
  • Multiomics Used To Stratify Multiple Myeloma Patients Into Affinity Groups

    Jan 6, 2022, 01:00 AM by User Not Found
    Bio-IT World | All new multiple myeloma patients being treated at the Tisch Cancer Institute at Mount Sinai are now being assigned to one of 12 subgroups based on shared genetic and molecular features of their disease. The multiple myeloma patient similarity network (MM-PSN) is one of the latest computational modeling tools being used here to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to the stratification of patients with the blood cancer.
    Full story
  • Overlooked Impact Of Cardiometabolic Drugs On The Gut Microbiome

    Jan 5, 2022, 01:00 AM by User Not Found
    Bio-IT World | A large-scale study involving more than 2,000 individuals across three countries could help disentangle associations between cardiometabolic disease, the gut microbiome, and metabolic markers in the blood—and, perhaps most importantly, the potential role played by the most prescribed drug treatments.
    Full story
  • Is Excel Holding Back Biopharmaceutical Research?

    Jan 3, 2022, 16:22 PM by User Not Found
    Bio-IT World | Data aggregation and consolidation are essential in biopharmaceutical development. Research teams use a wide range of analytical and sensor data from various instruments, which are often spread across multiple sites. These data streams need a common platform to allow scientists to review the data and make decisions. Excel is used to perform this consolidation in many companies, but while access to Excel is convenient, this software is the root cause of many data management problems.
    Full story
  • «
  • 151
  • 152
  • 153
  • 154 (current)
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy